Aarti Pharmalabs Share Price

Aarti Pharmalabs Share Price

NSE: AARTIPHARM
|
Pharmaceuticals
|
S Cap
₹ 883.75
+₹37.30 (4.41%)
1D
Last updated 22 Sep, 2026, 15:54 IST

Aarti Pharmalabs Share Price Today

As of 23 Sep 2026, Aarti Pharmalabs share price is ₹883.75. The stock opened at ₹862.00, compared to its previous close of ₹846.45. During today's trading session, Aarti Pharmalabs share price moved in the range of ₹861.20 to ₹909.50, with an average price of ₹885.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹585.00 and a high of ₹932.60. On the performance front, Aarti Pharmalabs share price has increased by 37.10% over the last six months and is down 1.81% on a year-on-year basis.

₹861.20
4.41% up today
₹909.50
1D LOW
1D HIGH

Aarti Pharmalabs Returns Calculator

Circuit
L
H
₹707.00
₹1,060.50
52-week
L
H
₹585.00
₹932.60

About Aarti Pharmalabs

Aarti Pharmalabs Share Price
ISIN
INE0LRU01027
Sector Market Cap
₹ 8,012.01 Cr

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.

Aarti Pharmalabs Financial Highlights

  • Revenue: Aarti Pharmalabs reported revenue of ₹1,829.19 crore in FY26 vs ₹2,125.19 crore in FY25. It showed a decrease of 13.93% on a yearly basis.
  • Operating Profit: Aarti Pharmalabs reported an operating profit of ₹232.92 crore in FY26 vs ₹360.69 crore in FY25. It showed a decrease of 35.42% on a year-on-year basis.
  • Net Profit: Aarti Pharmalabs reported a net profit of ₹174.71 crore in FY26 vs ₹272.40 crore in FY25. It showed a decrease of 35.86% on a yearly basis.

Aarti Pharmalabs Quarterly Result Highlights

  • Aarti Pharmalabs reported revenue of ₹536.25 crore in Jun 2026, compared with ₹590.69 crore in Mar 2026, representing a decrease of 9.22% on a quarter-on-quarter (QoQ) basis.
  • Aarti Pharmalabs reported an operating profit of ₹101.06 crore in Jun 2026, compared with ₹81.68 crore in Mar 2026, representing an increase of 23.73% on a quarter-on-quarter (QoQ) basis.
  • Aarti Pharmalabs reported a profit of ₹76.14 crore in Jun 2026, compared with ₹61.12 crore in Mar 2026, reflecting an increase of 24.57% on a QoQ basis.
  • The earnings per share (EPS) of Aarti Pharmalabs stood at ₹30.06 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
42.86%
FII
8.17%
Other DII
6.43%
Retail and other
41.74%
Mutual funds
0.79%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20258.02%
Dec 20257.68%
Mar 20268.39%
Jun 20268.17%
Mkt Cap Cr
8,012.01
P/E
37.58
P/B
3.77
ROE
8.22%
D/E
0.38
ROCE
9.59%
Div. Yield
0.41%
EPS(TTM)
19.44
Turnover
0.59
EV/EBITDA
18.76
Net Margin
9.80%
Op. Margin
21.44%
ROA
6.12%
Quick Ratio
0.82
Curr. Ratio
3.40
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aarti Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Aarti Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Aarti Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aarti Pharmalabs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,115.07₹1,852.61₹1,945.23₹1,199.94
Other Income₹10.12₹4.90₹2.32₹2.51
Total Revenue₹2,125.19₹1,857.50₹1,947.55₹1,202.46
Total Expenses₹1,764.50₹1,557.01₹1,686.78₹1,047.07
Profit Before Tax₹360.69₹300.49₹260.77₹155.38
Tax₹88.28₹83.59₹67.28₹33.13
Profit After Tax₹272.40₹216.90₹193.49₹122.25
EPS - Basic₹30.06₹23.93₹21.35₹13.49
EPS - Diluted₹30.04₹23.93₹21.35₹13.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹227.72₹360.69₹300.49₹260.77
Income before WC changes₹415.82₹480.97₹395.14₹344.13
Change in Assets-₹177.20-₹29.39-₹165.20-₹161.83
Change in Liabilities₹70.25-₹56.91₹43.35₹130.20
Change in WC-₹106.96-₹86.31-₹121.85-₹31.63
Cash flow from Operations₹261.93₹330.14₹216.35₹250.12
Cash flow from Investing-₹430.72-₹412.48-₹214.56-₹157.80
Cash flow from Financing₹170.58₹65.43₹9.72-₹163.46
Total Cash Flow₹1.80-₹16.90₹11.51-₹71.15
Cash (Start of the year)₹6.73₹23.63₹12.12₹83.27
Cash (End of the year)₹8.53₹6.73₹23.63₹12.12

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,584.24₹1,236.46₹1,081.02₹1,011.75
Current Assets₹1,322.17₹1,345.64₹1,163.01₹1,028.15
Total Assets₹2,906.41₹2,582.11₹2,244.02₹2,039.90
Current Liabilities₹657.05₹694.39₹600.62₹580.67
Net Current Asset₹665.12₹651.25₹562.38₹447.48
Non-Current Liabilities₹259.45₹130.68₹84.91₹72.76
Equity Capital₹1,989.91₹1,757.04₹1,558.49₹1,386.48
Total Equity & Liabilities₹2,906.41₹2,582.11₹2,244.02₹2,039.90

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,797.55₹1,771.35₹1,502.13₹1,511.25
Other Income₹15.32₹12.80₹11.01₹1.28
Total Revenue₹1,812.87₹1,784.15₹1,513.14₹1,512.53
Total Expenses₹1,575.84₹1,447.81₹1,238.62₹1,279.17
Profit Before Tax₹234.24₹336.34₹274.52₹233.36
Tax₹58.04₹78.99₹73.87₹61.63
Profit After Tax₹176.20₹257.35₹200.65₹171.73
EPS - Basic₹19.44₹28.39₹22.14₹18.95
EPS - Diluted₹19.42₹28.38₹22.14₹18.95

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹234.24₹336.34₹274.52₹233.36
Income before WC changes₹417.66₹445.63₹355.23₹310.23
Change in Assets-₹194.50-₹87.56-₹168.87-₹129.45
Change in Liabilities₹80.84₹39.02₹44.32₹91.84
Change in WC-₹113.66-₹48.55-₹124.55-₹37.61
Cash flow from Operations₹257.26₹338.58₹183.69₹215.88
Cash flow from Investing-₹425.14-₹418.38-₹184.40-₹115.55
Cash flow from Financing₹170.58₹78.63₹4.40-₹156.53
Total Cash Flow₹2.70-₹1.16₹3.70-₹56.20
Cash (Start of the year)₹2.84₹4.00₹0.30₹56.50
Cash (End of the year)₹5.54₹2.84₹4.00₹0.30

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,934.33₹1,510.81₹1,162.85₹1,010.15
Current Assets₹1,393.43₹1,208.82₹1,134.06₹966.22
Total Assets₹3,327.76₹2,719.63₹2,296.91₹1,976.37
Current Liabilities₹925.88₹618.76₹555.58₹463.75
Net Current Asset₹467.55₹590.06₹578.48₹502.47
Non-Current Liabilities₹419.53₹257.00₹119.87₹74.04
Equity Capital₹1,982.35₹1,843.87₹1,621.46₹1,438.58
Total Equity & Liabilities₹3,327.76₹2,719.63₹2,296.91₹1,976.37
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
883.75
2105
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2105
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.8
Neutral
ATR (14)
38.08
Neutral
STOCH(9,6)
82.18
Bearish
STOCH RSI (14)
92.54
Bearish
ADX(9)
25.46
Bearish
UO(9)
49.54
Neutral
ROC(12)
1.8
Bullish
WillR(14)
-17.82
Bearish
Period
Simple value
Exponential vaue
5D
838.11
847.61
10D
832.93
840.4
20D
841.13
833.76
50D
785.48
797.57
100D
737.92
762.39
Volume trend — traded volume by day
22 Sep14L
21 Sep24L
18 Sep19L
17 Sep2L
16 Sep3L
Average12L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Aarti Pharmalabs Share Price
Aarti Pharmalabs
Pharmaceuticals
Add Stock
Add Another

Aarti Pharmalabs Share Price FAQs

Aarti Pharmalabs share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837